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Glucose-induced insulin release and modifications in s6Rb outflow were studied in cultured neonatal and adult rat islets. 
The dose-response curve for neonatal islets was steeper than for adult islets and the maximal response was clearly shifted 
towards lower glucose concentrations. In neonatal islets, glucose-induced insulin release was inhibited by the Ca2+-chan- 
nel blocker. nifedipine. In the absence of glucose, the 86Rb outflow from neonatal islets was lower than from adult islets. 
Also, the glucose-induced reduction in 86Rb outflow was less pronounced in neonatal islets. Altered K+ permeability in 
the B-cell membrane could explain the change in glucose sensitivity of neonatal islets. 
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1. INTRODUCTION 
Insulin secretion in response to glucose has con- 
sistently been reported to be lower in fetal and 
neonatal islets than in adult islets [l-.5]. Similarly, 
other substrates which must be metabolized to in- 
duce insulin release, like glyceraldehyde and 
leucine, also show a reduced response [2,4,5]. 
Since theophylline strongly potentiates glucose- 
induced insulin secretion, the mechanism of ex- 
ocytosis seems to be operative in these immature 
islets [4,5]. Furthermore, the range of glucose con- 
centrations over which the islets respond (glucose 
sensitivity) has been reported to be narrowed in 
neonatal islets [2,3]. The nature of these abnor- 
malities is not yet fully elucidated. Metabolic 
‘defects’ have been proposed as the underlying 
disorder [2,6], however, the stimulus coupling be- 
tween metabolism of the fuels and the K+ channels 
may also be affected [7]. Here, we have compared 
the glucose responsiveness of neonatal and adult 
rat islets cultured under the same conditions. The 
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range of glucose concentrations to which the 
neonatal islets respond is reduced. Also, we have 
observed that 86Rb efflux from neonatal islets in 
the absence of glucose is lower than in adult islets 
and less affected by glucose. 
2. MATERIALS AND METHODS 
2.1. Animals 
Wistar rats were obtained from the NIH animal facility. 
Neonatal rats were less than 36 h old and adult rats were 3 
months old. Islets were obtained as described from neonatal 
rats [8,9] and adult rats [IO]. 
2.2. Tissue culrure 
The medium for culture was composed of EMEM (Biofluids, 
Rockville, MD) with 10% fetal calf serum (Biofluids). The ex- 
plant fragments from IO-12 neonatal animals were distributed 
in 4 plastic 100.mm culture dishes (Falcon 3003) with 10 ml 
culture medium and maintained at 37°C in an atmosphere of 
5% COZ. After 24 h the medium was changed and the 
fragments transferred to new culture dishes. Culture dishes and 
medium were renewed every 48 h. The islets obtained from 
adult rats were maintained in identical medium. The medium 
was changed every 48 h. Neonatal and adult islets were kept in 
culture for 7-9 days before use. 
2.3. Experimental protocol 
To measure insulin release, groups of neonatal islets were 
transferred to IO-mm plastic dishes 2 days before the experi- 
Published by Elsevier Science Publishers B. V. fBiomedical Division) 
00145793/88/$3.50 ‘c’ 1988 Federation of European Biochemical Societies 375 
Volume 236, number 2 FEBS LETTERS August 1988 
ment. The culture medium was then discarded and the islets 
were washed with a bicarbonate-buffered solution containing 
(mM): 115 NaCI, 5 KCI, 1 CaCIl, 1 MgC12, 24 NaHCOI, sup- 
plemented with 3 mg/ml of bovine serum albumin (Armour 
Pharmaceuticals, Eastbourne, England), preincubated for 
60 min in identical medium and finally incubated in 1 ml for 
another period of 60 min at 37°C and equilibrated with a mix- 
ture of 95% 02/5% CO*. At the end of the incubation period, 
an aliquot of the medium was drawn for insulin measurements 
and the insulin content of the islets was extracted with 2 ml 
acid-ethanol. The same procedure was followed for adult islets, 
with the exception that the experiments were done with groups 
of 5 islets each, transferred to the incubation vials immediately 
before use. Insulin release during incubation for 60 min was ex- 
pressed as a percentage of the islet insulin content at the end of 
incubation. 
The method used to measure 86Rb efflux and insulin release 
from perifused islets has been described [11,12]. In this case, the 
insulin was expressed as pg/islet per min. 86Rb efflux being ex- 
pressed as fractional outflow rate (% of instantaneous islet con- 
tent per min). 
Nifedipine was dissolved in dimethyl sulfoxide. The same 
amount of solvent was present in the control media (1 PI/ml). 
Immunoreactive insulin from the incubation media, perifused 
samples and extracts was measured as in [I31 using pork insulin 
as a standard. All results are expressed as means & SE together 
with the number of individual experiments (n). The statistical 
significance of differences between mean experimental and con- 
trol data was assessed by Student’s t-test. 
3. RESULTS 
Fig.1 illustrates the stimulatory effects of 
glucose, theophylline and glyceraldehyde on 
neonatal rat islets kept in culture for 9 days. The 
basal insulin release measured during 1 h of in- 
cubation in the absence of glucose averaged 0.54% 
of the total insulin content of the islets. Glucose 
(16.7 mM) and glyceraldehyde (10 mM) stimulated 
insulin release 2.1-fold @ < 0.05, in both cases). 
Glucose (5.6 mM) did not significantly increase 
secretion over basal value. However, addition of 
10 mM theophylline in the presence of 5.6 mM 
glucose increased insulin release 3.0-fold over 
basal @ < 0.01). 
The insulin response to various concentrations 
of glucose of neonatal and adult islets is compared 
in fig.2. Both types of islets show a sigmoidal 
response to glucose. The threshold for glucose- 
stimulated release was shifted slightly towards 
higher concentrations of glucose for the adult 
islets. Peak release occurred at a lower concentra- 
tion of glucose in the neonatal than in the adult 
islets, namely at 11.1 and 16.7 mM, respectively. It 
is clear that the dose-response curve for neonatal 
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Fig.1. Effects of glucose, theophylline and glyceraldehyde on 
insulin release from neonatal rat islets. After 7-9 days in 
culture, the islets were incubated for I h in a medium 
containing the indicated concentration of glucose, theophylline 
or glyceraldehyde. Values are means f SE for 5- I1 batches of 
islets. Statistical differences are related to basal values 
measured in the absence of glucose (* p < 0.05 and ** p < 
0.01). 
islets is steeper than for adult islets, the half- 
maximal response corresponding to about 7.3 and 
11.9 mM for neonatal and adult islets, respective- 
ly. In both cases, peak release corresponded to just 
over 1% per h of the total insulin content. 
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Fig.2. Insulin release induced by various concentrations of 
glucose in neonatal (- ) and adult (O---O) rat islets. Values 
are means + SE for 5-17 batches of islets incubated for 1 h. 
Statistical differences are related to the respective basal value at 
2.8 mM glucose (* p < 0.05 and ** p < 0.01). 
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Fig.3. Effect of glucose and nifedipine on insulin release from 
neonatal rat islets. The perifusate contained 2.8 mM glucose 
(G) from the onset of perifusion until min 44. Glucose was 
increased to 10 mM at min 45 and 10 gM nifedipine (NIF) was 
added at min 75 in the continued presence of 10 mM glucose, 
as indicated over the figure. Batches of 200-250 islets were 
perifused in each experiment; values are means k SE of 4 
experiments. 
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Fig.4. Effect of glucose at 2.8 mM (A) and 8.3 mM (B) on 86Rb 
fractional outflow rate from neonatal (e) and adult (0) rat 
islets. Values are means k SE of 4 experiments. 
Insulin release measured in perifused neonatal 
islets is illustrated in fig.3. An increase in glucose 
concentration from 2.8 to 10 mM rapidly 
augmented the secretion of insulin, peak secretion 
being reached within 9 min and then slowly 
decreasing with time. The mean insulin release dur- 
ing the control period in the presence of 2.8 mM 
glucose (min 31-44) averaged 4.15 + 0.7 pg/islet 
per min (n = 4). During exposure to 10 mM 
glucose (min 45-75), insulin secretion averaged 
10.2 f 1.4 pg/islet per min (n = 4) @ < O.Ol), 
representing an increase of about 2.5fold over 
basal. Nifedipine inhibited the glucose-induced in- 
sulin release; the mean value (min 76-100) was 
4.65 + 0.8 pg/islet per min (n = 4), not significant- 
ly different from the control period @ > 0.3). 
Preliminary experiments indicate that another 
Ca’+-channel blocker, w-conotoxin, did not inhibit 
insulin release from neonatal islets (not shown). 
Fig.4 shows the effect of different glucose con- 
centrations on 86Rb efflux from perifused neonatal 
and adult islets. In the absence of glucose, the 86Rb 
efflux is lower than from adult islets (fig.4A). 
Mean values (min 30-40) averaged 3.06 f 0.05 and 
3.93 f 0.06% per min, respectively (n = 4) @ < 
0.025). The addition of 2.8 mM glucose reduced 
the 86Rb efflux 36% from neonatal and 58% from 
adult islets; average values (min 50-60) were 
1.97 + 0.02% per min (p < 0.01) and 1.65 f 
0.02% per min @ < O.OOl), respectively. 
Fig.4B shows that increasing glucose concentra- 
tion from 2.8 to 8.3 mM further inhibits “Rb ef- 
flux. The inhibition is greater in adult than in 
neonatal islets. The mean values (min 50-60) 
averaged 1.73 f 0.01 and 1.25 k 0.02 (n = 4) % 
per min for neonatal and adult islets, respectively. 
4. DISCUSSION 
The present results indicate that neonatal rat 
islets, maintained in culture for 7-9 days, respond 
to glucose, glyceraldehyde and theophylline 
(fig.l). Basal insulin release (60 min) corresponds 
to approx. 0.5% of the total insulin content in the 
islets. Maximum release, induced by glucose, is 
about 2.5-times the basal value, comparable to 
that obtained by other investigators using fetal 
[5,7] or neonatal rat islets [2,7]. The glucose- 
induced insulin release is inhibited by nifedipine in 
neonatal islets (fig.3), as in adult islets [14], in- 
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dicating that these islets contain dihydropyridine- 
sensitive Ca’+ channels and that glucose-induced 
insulin secretion is dependent on Ca’+ entry. This 
is in contrast to recent observations in fetal rat 
islets (21 days), showing that glucose failed to in- 
crease 45Ca2+ uptake [1] and that glucose-induced 
insulin release in fetal islets was not blocked by 
verapamil [7]. 
Insulin release from neonatal islets was lower 
than from freshly isolated adult islets [2]. 
However, when adult islets were maintained in 
culture, glucose-induced insulin release was also 
reduced. This may be related to the composition of 
the culture medium which only contained 5.6 mM 
glucose [8]. In spite of the lower secretion by adult 
islets in culture, the sigmoidal response to glucose 
was preserved (fig.2). In neonatal islets, cultured 
under identical conditions, the values of half- 
maximal and maximal stimulation were clearly 
shifted to the lower glucose concentrations. 
Similar results, showing a narrowed response to 
glucose, were reported in freshly isolated neonatal 
islets [2], isolated neonatal B-cells [15] and fetal 
pancreas [3]. 
In the absence of glucose, the S6Rb efflux is 
lower in neonatal than in adult islets (fig.4A). Fur- 
thermore, the glucose-induced reduction in 86Rb 
efflux is smaller in neonatal islets (fig.4A,B). 
Recently, Ammon et al. [l] failed to detect any 
reduction in 86Rb efflux when increasing glucose 
from 3 to 16.7 mM in collagenase-isolated islets 
from 21-day fetal rats. These results indicate that 
in these immature islets, the K+ channels (whose 
activity mainly determines the Rb+ efflux) show an 
effective low density and/or an altered behavior. 
Two of the K+ channels identified in neonatal 
and adult isolated B-cells are the ATP-blockable 
(sulfonylurea-blockable) K+-channel [16-181 and 
the Ca’+-activated (voltage-gated) K+-channel 
[19,20]. Both have been observed to be inhibited 
by glucose in adult rat B-cells [21]. Recent observa- 
tions have shown that the K+-[ATP] channel is in- 
sensitive to glucose in B-cells from fetal rats, 
although it can be inhibited by the sulfonylurea, 
tolbutamide [22]. However, glipizide, another 
sulfonylurea also reported to inhibit K+-[ATP] 
channels, does not increase insulin secretion from 
fetal B-cells [23]. On the other hand, diazoxide, 
reported to stimulate K+-[ATP] channels, inhibits 
glucose-induced insulin release in fetal rat islets 
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maintained in culture [5]. The K+-[ATP] channel is 
regulated by cell metabolism [18,24]. It may be 
that the alteration in glucose sensing is due to a 
change in metabolism [2,6] or to a functional 
alteration of the K+-[ATP] channel, as recently 
suggested [7]. On the other hand, cytosolic Ca2+ 
handling in neonatal islets may be altered, and this 
may, in turn, affect the activity of the K’-[Ca”] 
channel. 
In conclusion, it is proposed that the decreased 
range of glucose sensitivity observed in neonatal 
islets is due to altered K+ permeability of the B-cell 
membrane. This may be due to alterations in the 
K’ channels themselves, or in the cell metabolism 
which controls their activity. 
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